CVS Health Co. (NYSE:CVS) Shares Bought by Atlas Brown Inc.

Atlas Brown Inc. grew its position in shares of CVS Health Co. (NYSE:CVSGet Rating) by 1.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,833 shares of the pharmacy operator’s stock after acquiring an additional 167 shares during the quarter. Atlas Brown Inc.’s holdings in CVS Health were worth $911,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of CVS. Norges Bank acquired a new stake in CVS Health in the fourth quarter worth about $1,346,805,000. Capital World Investors lifted its holdings in CVS Health by 17.0% in the first quarter. Capital World Investors now owns 58,633,421 shares of the pharmacy operator’s stock worth $5,934,465,000 after purchasing an additional 8,531,311 shares during the period. Vanguard Group Inc. lifted its holdings in CVS Health by 2.4% in the first quarter. Vanguard Group Inc. now owns 111,865,662 shares of the pharmacy operator’s stock worth $11,321,923,000 after purchasing an additional 2,628,740 shares during the period. Capital Research Global Investors acquired a new stake in CVS Health in the first quarter worth about $262,167,000. Finally, State Street Corp lifted its holdings in CVS Health by 4.3% in the first quarter. State Street Corp now owns 59,261,304 shares of the pharmacy operator’s stock worth $5,997,837,000 after purchasing an additional 2,450,990 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insiders Place Their Bets

In other CVS Health news, EVP Thomas M. Moriarty sold 138,654 shares of the company’s stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the completion of the sale, the executive vice president now owns 626,273 shares of the company’s stock, valued at $59,495,935. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Alan Lotvin sold 22,541 shares of the stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total value of $2,344,264.00. Following the completion of the sale, the executive vice president now directly owns 109,183 shares of the company’s stock, valued at $11,355,032. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Thomas M. Moriarty sold 138,654 shares of the stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total value of $13,172,130.00. Following the completion of the sale, the executive vice president now directly owns 626,273 shares of the company’s stock, valued at $59,495,935. The disclosure for this sale can be found here. Company insiders own 0.69% of the company’s stock.

CVS Health Stock Down 2.2 %

Shares of NYSE CVS traded down $2.22 during trading hours on Friday, hitting $97.61. The stock had a trading volume of 257,546 shares, compared to its average volume of 4,398,985. The company has a market capitalization of $128.15 billion, a P/E ratio of 15.91, a P/E/G ratio of 1.52 and a beta of 0.73. The firm’s 50-day moving average price is $100.14 and its two-hundred day moving average price is $99.28. CVS Health Co. has a 52 week low of $81.78 and a 52 week high of $111.25. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.65 and a current ratio of 0.91.

CVS Health (NYSE:CVSGet Rating) last announced its quarterly earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 EPS for the quarter, beating the consensus estimate of $2.16 by $0.24. The business had revenue of $80.64 billion during the quarter, compared to analysts’ expectations of $76.38 billion. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.42 EPS. Analysts anticipate that CVS Health Co. will post 8.53 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 1st. Shareholders of record on Friday, October 21st will be given a dividend of $0.55 per share. The ex-dividend date is Thursday, October 20th. This represents a $2.20 dividend on an annualized basis and a yield of 2.25%. CVS Health’s payout ratio is currently 35.77%.

Analyst Upgrades and Downgrades

CVS has been the topic of several research reports. Tigress Financial boosted their price target on shares of CVS Health from $125.00 to $130.00 in a research report on Wednesday, August 17th. Credit Suisse Group boosted their price target on shares of CVS Health from $113.00 to $117.00 and gave the stock an “outperform” rating in a research report on Monday, August 8th. Evercore ISI boosted their price target on shares of CVS Health from $120.00 to $125.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 7th. Mizuho boosted their price target on shares of CVS Health from $115.00 to $120.00 and gave the stock a “buy” rating in a research report on Monday, August 15th. Finally, Loop Capital assumed coverage on shares of CVS Health in a research report on Thursday, June 16th. They issued a “buy” rating and a $120.00 price target on the stock. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $117.59.

CVS Health Company Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

See Also

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.